Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean E Egan

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2007
High-level JAG1 mRNA and protein predict poor outcome in breast cancerBrendan C Dickson, Anna Marie Mulligan, Hui Zhang, et al.
Plos One|September 21, 2011
Notch3 is dispensable for thymocyte β-selection and Notch1-induced T cell leukemogenesisSara Suliman, Joanne Tan, Keli Xu, et al.
Neurobiology of Learning and Memory|July 16, 2013
Reprint of: disrupting Jagged1-Notch signaling impairs spatial memory formation in adult miceDerya Sargin, Leigh C P Botly, Gemma Higgs, et al.
Neurobiology of Learning and Memory|April 10, 2013
Disrupting Jagged1-Notch signaling impairs spatial memory formation in adult miceDerya Sargin, Leigh C P Botly, Gemma Higgs, et al.
International Journal of Oncology|November 21, 2008
Activation of Notch signaling in human colon adenocarcinomaMichael Reedijk, Silvia Odorcic, Hui Zhang, et al.
Blood|March 28, 2012
The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in miceYanmei Li, Laura M Vecchiarelli-Federico, You-Jun Li, et al.
Breast Cancer Research and Treatment|June 20, 2008
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumorsAnita L Bane, Dushanthi Pinnaduwage, Sarah Colby, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2013
High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factorsTyler J W Robinson, Melody Pai, Jeff C Liu, et al.
Plos One|November 23, 2013
RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugsTyler J W Robinson, Jeff C Liu, Frederick Vizeacoumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2012
Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancerJeff C Liu, Veronique Voisin, Gary D Bader, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2007
High-level JAG1 mRNA and protein predict poor outcome in breast cancerBrendan C Dickson, Anna Marie Mulligan, Hui Zhang, et al.
Plos One|September 21, 2011
Notch3 is dispensable for thymocyte β-selection and Notch1-induced T cell leukemogenesisSara Suliman, Joanne Tan, Keli Xu, et al.
Neurobiology of Learning and Memory|July 16, 2013
Reprint of: disrupting Jagged1-Notch signaling impairs spatial memory formation in adult miceDerya Sargin, Leigh C P Botly, Gemma Higgs, et al.
Neurobiology of Learning and Memory|April 10, 2013
Disrupting Jagged1-Notch signaling impairs spatial memory formation in adult miceDerya Sargin, Leigh C P Botly, Gemma Higgs, et al.
International Journal of Oncology|November 21, 2008
Activation of Notch signaling in human colon adenocarcinomaMichael Reedijk, Silvia Odorcic, Hui Zhang, et al.
Blood|March 28, 2012
The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in miceYanmei Li, Laura M Vecchiarelli-Federico, You-Jun Li, et al.
Breast Cancer Research and Treatment|June 20, 2008
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumorsAnita L Bane, Dushanthi Pinnaduwage, Sarah Colby, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2013
High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factorsTyler J W Robinson, Melody Pai, Jeff C Liu, et al.
Plos One|November 23, 2013
RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugsTyler J W Robinson, Jeff C Liu, Frederick Vizeacoumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2012
Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancerJeff C Liu, Veronique Voisin, Gary D Bader, et al.
Pageof 6